Submitted by Cássia Santos (cassia.bcufg@gmail.com) on 2014-09-02T14:56:13Z
No. of bitstreams: 2
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Dissertacao Sheila Alves Pereira.pdf: 1561481 bytes, checksum: f5f41f977316e7afcdb4b84f89a0a92f (MD5) / Made available in DSpace on 2014-09-02T14:56:13Z (GMT). No. of bitstreams: 2
license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)
Dissertacao Sheila Alves Pereira.pdf: 1561481 bytes, checksum: f5f41f977316e7afcdb4b84f89a0a92f (MD5)
Previous issue date: 2013-05-06 / Introduction: The detection of patients with Chronic Obstructive Pulmonary Disease (COPD) on the primary health care network can be an important tool for an early diagnosis and better conduct management of these patients. Studies realized in Latin America (MENEZES, 2006) show that the COPD underdiagnosis is one of the great limiters for the control of this illness. It was also observed in a study in Canada (Hill et al., 2010) that half of the cases sub-diagnosed were of hypertensive patients. Thus, the analysis of the pulmonary function in hypertensive patients could be a useful strategy for the diagnosis of patients with COPD. Objective: To estimate the prevalence of COPD and its sub-diagnosis on hypertensive patients registered on the HIPERDIA Program of an unit of primary health care in Goiânia. Methodology: The transversal analytical study performed on the Novo Horizonte CIAMS in Goiânia from January/2011 to May/2012, with patients from both sex, aged between 18 and 80 years old and hypertensive registered on the HIPERDIA Program. The patients were evaluated as for the pulmonary function (spirometry) and the respiratory symptoms (questionnaire). The criteria used for the diagnosis f COPD were in fixed relation of the VEF1/CVT<0,70 or by the relation VEF1/CVF below the inferior limit of normality. For the statistical analysis, it was appealed to the SPSS 17.0 program, with the execution of the square Qui test, T test and analysis of the logistical regression. The level of statistic significance assumed was of p < 0,05. The present study was approved by the Ethical Committee of Human Research from the Clinical Hospital of the Federal University of Goiás, register n° 159/2010. Results: 301 patients were evaluated. The prevalence of COPD was of 22,2% and the sub-diagnosis rate was of 82%. The group with normal spirometry (n=165) was compared to the group with COPD (n=67) as for the social demographic variables, pulmonary function, risk factors, the respiratory symptoms and the co morbidity. There were significant differences only in relation to the sex (p<0,001), age (p=0,005), CVF, VEF1/CVF (p<0,001), smoking (p<0,001) and wheezing (p=0,006). The group of patients with sub-diagnosed with COPD (n=55) and with previous diagnosis (n=12) were similar as for all the variables of epidemiological characterization, except for the respiratory symptoms (wheezing and dyspnea) and pulmonary function. Conclusion: The COPD patients’ profile is similar to the literature. The high prevalence of COPD found in the patients on the HIPERDIA Program with the majority of the sub-diagnosed, shows that the implantation of management strategies with patients with COPD in this National Program of Public Health is already existent in the majority of the Brazilian cities. / Introdução: A detecção de pacientes com Doença Pulmonar Obstrutiva Crônica (DPOC) na rede de atenção primária de saúde pode ser uma ferramenta importante para diagnóstico precoce e melhor manejo na conduta desses pacientes. Estudos realizados na América Latina (MENEZES, 2006) demonstraram que o subdiagnóstico de DPOC é um dos grandes limitadores para o controle dessa enfermidade. Também foi observado em um estudo no Canadá (HILL et al., 2010) que metade dos casos subdiagnosticados era de pacientes hipertensos. Sendo assim, a análise da função pulmonar em pacientes hipertensos poderá ser uma estratégia útil para o diagnóstico de pacientes com DPOC. Objetivo: Estimar a prevalência de DPOC e de seu subdiagnóstico em pacientes hipertensos cadastrados no Programa HIPERDIA de uma unidade de atenção primária à saúde em Goiânia. Metodologia: Estudo transversal analítico realizado no CIAMS do Novo Horizonte da cidade de Goiânia no período de janeiro/2011 a Maio/2012, com pacientes de ambos os sexos idade entre 18 e 80 anos, hipertensos inscritos no Programa HIPERDIA. Os pacientes foram avaliados quanto à função pulmonar (espirometria) e aos sintomas respiratórios (questionário). Os critérios usados para diagnóstico de DPOC foram pela relação fixa do VEF1/CVF<0,70 ou pela relação VEF1/CVF abaixo do limite inferior da normalidade. Para análise estatística, recorreu-se ao programa SPSS 17.0, com a realização de teste Qui quadrado, teste t student e análise de regressão logística. O nível de significância estatística adotado foi de p < 0,05. O presente estudo foi aprovado pelo Comitê de Ética em Pesquisa Humana do Hospital das Clínicas da Universidade Federal de Goiás, registro nº 159/2010. Resultados: Foram avaliados 301 pacientes. A prevalência de DPOC foi de 22,2% e a taxa de subdiagnóstico foi de 82%. Comparou-se o grupo com espirometria normal (n=165) com o grupo DPOC (n=67) quanto às variáveis sociodemográficas, a função pulmonar, os fatores de risco, os sintomas respiratórios e as comorbidades. Houve diferenças significantes apenas em relação a sexo (p<0,001), idade (p=0,005), CVF, VEF1 e VEF1/CVF (p<0,001), fumo (p<0,001) e sibilos (p=0,006). Os grupos de pacientes com DPOC subdiagnosticados (n=55) e com diagnóstico prévio (n=12) foram semelhantes quanto a todas as variáveis de caracterização epidemiológica, exceto quanto aos sintomas respiratórios (sibilo e dispneia) e função pulmonar. Conclusão: O perfil dos pacientes DPOC é semelhante ao da literatura. A alta prevalência de DPOC encontrada nos pacientes do Programa HIPERDIA com maioria de subdiagnosticados sinaliza para implantação de estratégias de manejo de pacientes com DPOC nesse Programa de Saúde Pública Nacional já existente na maioria dos municípios brasileiros.
| Identifer | oai:union.ndltd.org:IBICT/oai:repositorio.bc.ufg.br:tde/2983 |
| Date | 06 May 2013 |
| Creators | Pereira, Sheila Alves |
| Contributors | Rabahi, Marcelo Fouad |
| Publisher | Universidade Federal de Goiás, Programa de Pós-graduação em Ciências da Saúde (FM), UFG, Brasil, Faculdade de Medicina - FM (RG) |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/masterThesis |
| Format | application/pdf |
| Source | reponame:Biblioteca Digital de Teses e Dissertações da UFG, instname:Universidade Federal de Goiás, instacron:UFG |
| Rights | http://creativecommons.org/licenses/by-nc-nd/4.0/, info:eu-repo/semantics/openAccess |
| Relation | -1006864312617745310, 600, 600, 600, 1545772475950486338, 7337577453819502453, AGUSTI, A. G. et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J, v. 21, n. 2, p. 347-60, Feb 2003. BAGATIN, E.; JARDIM, J. R. B.; STIRBULOV, R. Occupational chronic obstructive pulmonary disease. J Bras Pneumol, v. 32, p. S35-S40, 2006. BARNES, P. J. Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc, v. 5, n. 8, p. 857-64, Dec 1 2008. BARNES, P. J.; CELLI, B. R. Systemic manifestations and comorbidities of COPD. Eur Respir J, v. 33, n. 5, p. 1165-85, May 2009. BOSSE, Y. Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis, v. 7, p. 607-31, 2012. BRASIL. Ministério da Saúde. Avança Brasil - Programa Prevenção e Controle das Doenças Crônico-Degenerativas. 2011. www.abrasil.gov.br ______. Ministério da Saúde. Portal da saúde do Sistema Único de Saúde.Brasília-DF.2012a. http://portal.saude.gov.br/portal/saude/Gestor/visualizar_texto.cfm?idtxt=28166 ______. Ministério da Saúde. SISHIPERDIA. DATASUS. Brasília (DF). 2012b. http://hiperdia.datasus.gov.br/ ______. Ministério da Saúde. Sistema de Cadastramento e Acompanhamento de Hipertensos e Diabéticos.HIPERDIA. DATASUS. 2012c. http://hiperdia.datasus.gov.br/ ______. Ministério da saúde. Sistema de Informação de Atenção Básica. DATASUS.2012d. http://tabnet.datasus.gov.br/cgi/deftohtm.exe?siab/cnv/SIABSBR.DEF ______. Ministério da Saúde. Vigitel Brasil 2011: Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico. Brasília.2012e. http://portalsaude.saude.gov.br/portalsaude/arquivos/pdf/2012/Ago/22/vigitel_2011_final_0812.pdf ______. Ministério da Saúde Morbidade hospitalares do SUS. SIH/SUS. Informações de saúde (TABNET).2013. http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/niuf.def BTS. The burden of lung disease: a statistical report from the British Thoracic Society. 2nd ed. . London: British Thoracic Society2006. Disponível em: <http://www.britthoracic.org.uk/Portals/0/Library/BTS%20Publications/burdeon_of_lung_disease2007.pdf>. BUSATO, O. Hipertensão arterial. 2009. Disponível em: < http://abcdasaude.com.br >. Acesso em: 13/01/2013. CAMPOS, H. S. Doença Pulmonar Obstrutiva Crônica: mais do que apenas uma doença pulmonar. Bol Pneumol Sanit, v. 14, n. 1, p. 27-32, 2006. CAMPOS, H. S.; LEMOS, A. C. M. A asma e a DPOC na visão do pneumologista. J Bras Pneumol, v. 35, n. 4, p. 301-309, 2009. CARVALHO, T. D. Diretriz de reabilitação cardiopulmonar e metabólica: Aspectos práticos e responsabilidades. Arq Bras Cardiol, v. 86, p. 74-82, 2006. CDC. Chronic Obstructive Pulmonary Disease Among Adults — United States, 2011. MMWR Morb Mortal Wkly Rep, v. 6, n. 61, p. 938-943, 2012. CRUZ, F. O. A saúde no Brasil em 2030: diretrizes para a prospecção estratégica do sistema de saúde brasileiro. FIOCRUZ/IPEA/MINISTÉRIO DA SAÚDE/SECRETARIA DE ASSUNTOS ESTRATÉGICOS DA PRESIDÊNCIA DA REPÚBLICA. Rio de Janeiro. 2012. http://www.fiocruz.br/editora/media/Saude_Brasil_2030.pdf CURKENDALL, S. M. et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol, v. 16, n. 1, p. 63-70, Jan 2006. DANIELSSON, P. et al. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Clin Respir J, v. 6, n. 2, p. 120-7, Apr 2012. DANIELSSON, P. et al. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden–the Burden of Obstructive Lung Disease (BOLD) study: cross‐sectional population‐based study. The Clinical Respiratory Journal, v. 6, n. 2, p. 120-127, 2011. DE LUCAS-RAMOS, P. et al. [Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study]. Arch Bronconeumol, v. 44, n. 5, p. 233-8, May 2008. DE QUEIROZ, M. C.; MOREIRA, M. A.; RABAHI, M. F. Underdiagnosis of COPD at primary health care clinics in the city of Aparecida de Goiania, Brazil. J Bras Pneumol, v. 38, n. 6, p. 692-9, Nov-Dec 2012. DECRAMER, M. et al. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. COPD, v. 5, n. 4, p. 235-56, Aug 2008. DOURADO, V. Z. et al. Systemic manifestations in chronic obstructive pulmonary disease. J Bras Pneumol, v. 32, n. 2, p. 161-71, Mar-Apr 2006. EAGAN, T. M. et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J, v. 35, n. 3, p. 540-548, 2010. FEARY, J. R. et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax, v. 65, n. 11, p. 956-62, Nov 2010. FINKELSTEIN, J.; CHA, E.; SCHARF, S. M. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis, v. 4, p. 337-49, 2009. FOREMAN, M. G. et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med, v. 184, n. 4, p. 414-20, Aug 15 2011. GALE, N. S. et al. Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? BMC Pulm Med, v. 11, p. 20, 2011. GIACOMAZZI, C. M. O acesso aos programas de reabilitação pulmonar na rede pública de saúde; Access to pulmonary rehabilitation programs within the public healthcare service. Rev. bras. fisioter, v. 14, n. 4, p. 358-359, 2010. GOLD. Manual de espirometria. 2008. Disponível em: < www.goldcopd.org >. ______. Global strategy for the diagnosis, management and prevention of chronic pulmonary disease (UPDATE 2011) 2011. HAN, M. K. et al. Racial differences in quality of life in patients with COPD. Chest, v. 140, n. 5, p. 1169-76, Nov 2011. HILL, K. et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ, v. 182, n. 7, p. 673-8, Apr 20 2010. HOOPER, R. et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J, v. 39, n. 6, p. 1343-53, Jun 2012. IBGE. Censo demográfico 2010. 2010. http://censo2010.ibge.gov.br/sobre-censo JARDIM, P. C. et al. High blood pressure and some risk factors in a Brazilian capital. Arq Bras Cardiol, v. 88, n. 4, p. 452-7, Apr 2007. KHAN, N. A. et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. Can J Cardiol, v. 25, n. 5, p. 287-98, May 2009. KOHANSAL, R. et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med, v. 180, n. 1, p. 3-10, Jul 1 2009. LANÇAS, T. Responsividade do tecido pulmonar periférico de pacientes com doença pulmonar obstrutiva crônica; Hyperresponsiveness of peripheral lung parenchyma in chronic obstructive pulmonary disease. 2009. Doutorado em Patologia, Universidade de São Paulo. Faculdade de Medicina LANGE, P. et al. Cardiovascular morbidity in COPD: A study of the general population. COPD, v. 7, n. 1, p. 5-10, Feb 2010. LEVY, M. L. et al. Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1 www.gpiag.org 2 www.artp.org 3 www.educationforhealth.org.uk. Prim Care Respir J, v. 18, n. 3, p. 130-47, Sep 2009. LINDBERG, A. et al. Up-to-date on mortality in COPD - report from the OLIN COPD study. BMC Pulm Med, v. 12, p. 1, 2012. LOIVOS, L. P. COPD - definitions and concepts - clinical bases. Pulmão RJ - Atualizações Temáticas, v. 1, n. 1, p. 34-37, 2009. LYNGSØ, A. M. et al. Early detection of COPD in primary care-The Copenhagen COPD Screening Project. BMC public health, v. 10, n. 1, p. 524, 2010. MACHADO, M. C.; PIRES, C. G. D. S.; LOBÃO, W. M. Perceptions of hypertensive people on risk factors for the disease temas livres free themes. Ciênc. saúde colet., v. 17, n. 5, p. 1357-1363, 2012. MACLAY, J. D.; MCALLISTER, D. A.; MACNEE, W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology, v. 12, n. 5, p. 634-41, Sep 2007. MACLAY, J. D. et al. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, v. 180, n. 6, p. 513-20, Sep 15 2009. MENEZES, A. PLATINO: Projeto Latino-Americano de Investigação em Obstrução Pulmonar. 2006. Disponível em: < http://www.platino-alat.org/docs/livro_platino_pt.pdf >. MILLER, M. R. et al. Improved survival prediction from lung function data in a large population sample. Respir Med, v. 103, n. 3, p. 442-8, Mar 2009. MILLER, M. R. et al. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest, v. 139, n. 1, p. 52-9, Jan 2011. MINAS, M. et al. Two-year mortality of patients with COPD in primary health care: an observational study. Int J Gen Med, v. 5, p. 815-22, 2012. NASCIMENTO, A.; JARDIM, J. Avaliação do diagnóstico e tratamento da DPOC na região metropolitana de São Paulo (SP)–Estudo PLATINO–Uma amostra de base populacional. São Paulo: USP, 2006. NASCIMENTO, O. A. et al. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in Sao Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res, v. 40, n. 7, p. 887-95, Jul 2007. ORVOEN-FRIJA, E. et al. [Chronic obstructive pulmonary disease (COPD) in the elderly]. Rev Mal Respir, v. 27, n. 8, p. 855-73, Oct 2010. PASSOWICZ-MUSZYNSKA, E. et al. [Chronic obstructive pulmonary disease and cardiovascular diseases]. Pneumonol Alergol Pol, v. 78, n. 1, p. 28-32, 2010. PEREIRA, C. A.; SATO, T.; RODRIGUES, S. C. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol, v. 33, n. 4, p. 397-406, Aug 2007. PEREIRA, J. C.; BARRETO, S. M.; PASSOS, V. Perfil de risco cardiovascular e autoavaliação da saúde no Brasil: estudo de base populacional. Rev Panam Salud Publica, v. 25, n. 6, p. 491-8, 2009. PESSÔA, C. L. C.; PESSÔA, R. S. Epidemiologia a DPOC no presente–aspectos nacionais e internacionais. Pulmão RJ, v. 1, p. 7-12, 2009. QUANJER, P. H. et al. The need to change the method for defining mild airway obstruction. Eur Respir J, v. 37, n. 3, p. 720-2, Mar 2011. REICHERT, J. et al. Smoking cessation guidelines--2008. J Bras Pneumol, v. 34, n. 10, p. 845-80, Oct 2008. ROSA, F. W. et al. Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over. Braz J Med Biol Res, v. 40, n. 12, p. 1615-21, Dec 2007. RUTTEN, E. P. et al. The association between body composition and self-reported co-morbidity in subjects with chronic obstructive pulmonary disease. Op J Int Med, v. 15, n. 2, p. 100-106, 2012. SBC; SBH; SBN. VI Diretrizes Brasileiras de Hipertensão. Arq Bras Cardiol, v. 95, n. 1 supl, p. 1-51, 2010. SBPT. Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para testes de função pulmonar.J Pneumol, v. 3, n. 28, p. 1-221, 2002. SCARDUELLI, C. et al. Prevalence and prognostic role of cardiovascular complications in patients with exacerbation of chronic obstructive pulmonary disease admitted to Italian respiratory intensive care units. Ital Heart J, v. 5, n. 12, p. 932-8, Dec 2004. SCHMIDT, M. I. et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet, v. 377, n. 9781, p. 1949-61, Jun 4 2011. SCHNEIDER, C. et al. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol, v. 25, n. 4, p. 253-60, Apr 2010. SCHNELL, K. et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med, v. 12, p. 26, 2012. SIDNEY, S. et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest, v. 128, n. 4, p. 2068-75, Oct 2005. SORIANO, J. B.; ZIELINSKI, J.; PRICE, D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet, v. 374, n. 9691, p. 721-32, Aug 29 2009. ULRIK, C. S. et al. Early detection of COPD in general practice. Int J Chron Obstruct Pulmon Dis, v. 6, p. 123-7, 2011. VOLPINO, P. et al. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer. J Cardiovasc Surg (Torino), v. 48, n. 3, p. 375-83, Jun 2007. WAKED, M.; KHAYAT, G.; SALAMEH, P. Chronic obstructive pulmonary disease prevalence in Lebanon: a cross-sectional descriptive study. Clin Epidemiol, v. 3, p. 315-23, 2011. WARD, H.; COOPER, B.; MILLER, M. R. Validation of lung function prediction equations from patient survival data. Eur Respir J, v. 39, n. 5, p. 1181-7, May 2012. WEHRMEISTER, F. C. et al. Pulmonary rehabilitation programs for patients with COPD. J Bras Pneumol, v. 37, n. 4, p. 544-55, Jul-Aug 2011. WHO. The top 10 causes of death. World Health Organization website, v. 5, 2011. ZANCHET, R. C.; VIEGAS, C. A. A.; LIMA, T. A eficácia da reabilitação pulmonar na capacidade de exercício, força da musculatura inspiratória e qualidade de vida de portadores de doença pulmonar obstrutiva crônica. J Bras Pneumol, v. 31, n. 2, p. 118-24, 2005. |
Page generated in 0.0048 seconds